United States Healthcare Equipment & Supplies

Fulgent Genetics Inc (FLGT)

Track

Over the past 90 days, Fulgent Genetics Inc. insiders have engaged in five transactions, all of which were sales. Executives, including the President and COO and the Chief Scientific Officer, sold a net value of approximately $106,343. These transactions follow the company's most recent earnings report, where it missed EPS expectations by 2.86%.
Ticker: FLGT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fulgent Genetics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 2 Jun 2026
Value US$3,236,583.46 | Price 77.03 | Shares 82,938 (-42.6%)
Proposed sale 2 Jun 2026
Value US$1,420,022.57 | Price 441.26 | Shares 5,300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-03 2026-06-02 S Sale
3.8
Xie Jian

President and COO

Officer
82,938 -42.6%
77.03
US$3,236,583 		82,938 -42.6% 77.03 US$3,236,583
2026-06-03 2026-06-02 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
97,012 +46.2%
199.56
US$4,917,365 		97,012 +46.2% 199.56 US$4,917,365
2026-06-02 2026-06-02 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
5,300
441.26
US$1,420,023 		5,300 441.26 US$1,420,023
2026-05-28 2026-05-27 S Sale
3.8
Xie Jian

President and COO

Officer
1,201 -0.3%
17.60
US$21,138 		1,201 -0.3% 17.60 US$21,138
2026-05-28 2026-05-27 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
945 -0.1%
17.60
US$16,632 		945 -0.1% 17.60 US$16,632
2025-12-03 2025-12-02 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
1,075 -0.1%
28.33
US$30,457 		1,075 -0.1% 28.33 US$30,457
2025-12-03 2025-12-02 S Sale
3.8
Xie Jian

President and COO

Officer
1,140 -0.3%
28.33
US$32,298 		1,140 -0.3% 28.33 US$32,298
2025-12-01 2025-12-02 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
1,070
28.52
US$30,516 		1,070 28.52 US$30,516
2025-12-01 2025-12-02 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,135
28.52
US$32,370 		1,135 28.52 US$32,370
2025-12-01 2025-11-28 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
943 -0.1%
29.57
US$27,884 		943 -0.1% 29.57 US$27,884
2025-12-01 2025-11-28 S Sale
3.8
Xie Jian

President and COO

Officer
1,198 -0.4%
29.57
US$35,424 		1,198 -0.4% 29.57 US$35,424
2025-11-26 2025-11-28 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,198
30.15
US$36,120 		1,198 30.15 US$36,120
2025-11-26 2025-11-28 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
943
30.15
US$28,431 		943 30.15 US$28,431
2025-11-25 2025-11-24 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
535 -0.1%
30.47
US$16,303 		535 -0.1% 30.47 US$16,303
2025-11-25 2025-11-24 S Sale
3.8
Xie Jian

President and COO

Officer
681 -0.2%
30.47
US$20,752 		681 -0.2% 30.47 US$20,752
2025-11-24 2025-11-24 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
681
30.47
US$20,752 		681 30.47 US$20,752
2025-11-24 2025-11-24 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
535
30.47
US$16,303 		535 30.47 US$16,303
2025-11-19 2025-11-20 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
10,000
29.00
US$290,000 		10,000 29.00 US$290,000
2025-11-21 2025-11-19 S Sale
3.8
Xie Jian

President and COO

Officer
10,000 -2.8%
29.10
US$290,983 		10,000 -2.8% 29.10 US$290,983
2025-11-19 2025-11-19 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
10,000
29.10
US$290,983 		10,000 29.10 US$290,983
2025-09-03 2025-09-03 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,128
22.03
US$24,846 		1,128 22.03 US$24,846
2025-09-03 2025-09-03 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
1,063
22.03
US$23,414 		1,063 22.03 US$23,414
2025-09-03 2025-09-03 S Sale
3.8
Xie Jian

President and COO

Officer
1,128 -0.3%
22.03
US$24,846 		1,128 -0.3% 22.03 US$24,846
2025-09-03 2025-09-03 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
1,063 -0.1%
22.03
US$23,414 		1,063 -0.1% 22.03 US$23,414
2025-08-28 2025-08-27 S Sale
3.8
Xie Jian

President and COO

Officer
1,199 -0.3%
21.48
US$25,760 		1,199 -0.3% 21.48 US$25,760
2025-08-28 2025-08-27 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
943 -0.1%
21.48
US$20,260 		943 -0.1% 21.48 US$20,260
2025-08-27 2025-08-27 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,199
21.48
US$25,760 		1,199 21.48 US$25,760
2025-08-27 2025-08-27 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
943
21.48
US$20,260 		943 21.48 US$20,260
2025-08-27 2025-08-25 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
696
21.50
US$14,965 		696 21.50 US$14,965
2025-08-26 2025-08-25 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
548 -0.1%
21.50
US$11,783 		548 -0.1% 21.50 US$11,783
2025-08-26 2025-08-25 S Sale
3.8
Xie Jian

President and COO

Officer
696 -0.2%
21.50
US$14,965 		696 -0.2% 21.50 US$14,965
2025-08-25 2025-08-25 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
696
21.50
US$14,965 		696 21.50 US$14,965
2025-08-27 2025-06-02 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,135
20.29
US$23,030 		1,135 20.29 US$23,030
2025-06-03 2025-06-02 S Sale
3.8
Xie Jian

President and COO

Officer
1,135 -0.3%
20.29
US$23,030 		1,135 -0.3% 20.29 US$23,030
2025-06-03 2025-06-02 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
754 -0.1%
20.29
US$15,299 		754 -0.1% 20.29 US$15,299
2025-06-02 2025-06-02 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,135
20.29
US$23,030 		1,135 20.29 US$23,030
2025-05-28 2025-05-27 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
656 -0.1%
20.52
US$13,459 		656 -0.1% 20.52 US$13,459
2025-05-28 2025-05-27 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
383 -0.0%
20.58
US$7,880 		383 -0.0% 20.58 US$7,880
2025-05-28 2025-05-27 S Sale
3.8
Xie Jian

President and COO

Officer
1,183 -0.3%
20.52
US$24,271 		1,183 -0.3% 20.52 US$24,271
2025-05-28 2025-05-27 S Sale
3.8
Xie Jian

President and COO

Officer
690 -0.2%
20.58
US$14,197 		690 -0.2% 20.58 US$14,197
2025-03-05 2025-03-05 B Purchase
2.6
Kim Paul

CFO and Treasurer

Officer
100,000 +40.3%
15.96
US$1,596,470 		100,000 +40.3% 15.96 US$1,596,470
2024-12-04 2024-12-03 S Sale
3.8
Xie Jian

President and COO

Officer
1,455 -0.4%
19.50
US$28,372 		1,455 -0.4% 19.50 US$28,372
2024-12-04 2024-12-03 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
1,373 -0.1%
19.50
US$26,773 		1,373 -0.1% 19.50 US$26,773
2024-12-02 2024-12-02 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
1,397
19.25
US$26,892 		1,397 19.25 US$26,892
2024-12-02 2024-12-02 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,483
19.25
US$28,548 		1,483 19.25 US$28,548
2024-11-27 2024-11-25 S Sale
3.8
Xie Jian

President and COO

Officer
689 -0.2%
18.26
US$12,581 		689 -0.2% 18.26 US$12,581
2024-11-27 2024-11-25 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
497 -0.1%
18.26
US$9,075 		497 -0.1% 18.26 US$9,075
2024-11-27 2024-11-25 S Sale
3.8
Hsieh Ming

Chief Executive Officer

Executive Director Large shareholder
2,227 -0.3%
18.26
US$40,663 		2,227 -0.3% 18.26 US$40,663
2024-11-25 2024-11-25 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
689
18.26
US$12,581 		689 18.26 US$12,581
2024-11-25 2024-11-25 PrS Proposed sale
3.7
Gao Hanlin

Officer

Officer
497
18.26
US$9,075 		497 18.26 US$9,075
2024-11-25 2024-11-25 PrS Proposed sale
3.8
Hsieh Ming

Owner; Officer; Director

Executive Director
2,227
18.26
US$40,663 		2,227 18.26 US$40,663
2024-09-05 2024-09-03 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
1,503 -0.2%
21.96
US$33,007 		1,503 -0.2% 21.96 US$33,007
2024-09-05 2024-09-03 S Sale
3.8
Xie Jian

President and COO

Officer
1,594 -0.5%
21.96
US$35,006 		1,594 -0.5% 21.96 US$35,006
2024-09-05 2024-09-03 S Sale
2.6
Kim Paul

CFO and Treasurer

Officer
1,674 -0.8%
21.96
US$36,763 		1,674 -0.8% 21.96 US$36,763
2024-09-03 2024-09-03 PrS Proposed sale
3.8
Xie Jian

Officer

Officer
1,594
21.96
US$35,006 		1,594 21.96 US$35,006
2024-09-03 2024-09-03 PrS Proposed sale
2.6
Kim Paul

Officer

Officer
1,674
21.96
US$36,763 		1,674 21.96 US$36,763
2024-08-29 2024-08-27 S Sale
3.8
Hsieh Ming

Chief Executive Officer

Executive Director Large shareholder
2,313 -0.3%
22.83
US$52,813 		2,313 -0.3% 22.83 US$52,813
2024-08-29 2024-08-27 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
563 -0.1%
22.83
US$12,855 		563 -0.1% 22.83 US$12,855
2024-08-29 2024-08-27 S Sale
2.6
Kim Paul

CFO and Treasurer

Officer
733 -0.3%
22.83
US$16,737 		733 -0.3% 22.83 US$16,737
2024-08-29 2024-08-27 S Sale
3.8
Xie Jian

President and COO

Officer
715 -0.2%
22.83
US$16,326 		715 -0.2% 22.83 US$16,326
2024-08-27 2024-08-27 PrS Proposed sale
3.8
Hsieh Ming

Owner; Officer; Director

Executive Director
2,313
22.83
US$52,813 		2,313 22.83 US$52,813
2023-12-13 2023-12-11 S Sale
3.8
Xie Jian

President and COO

Officer
12,000 -3.2%
26.69
US$320,274 		12,000 -3.2% 26.69 US$320,274
2023-12-13 2023-12-11 S Sale
3.8
Xie Jian

President and COO

Officer
10,000 -2.6%
26.32
US$263,179 		10,000 -2.6% 26.32 US$263,179
2023-12-12 2023-12-11 PrS Proposed sale
3.8
Jian Xie

Officer

Officer
12,000
26.69
US$320,274 		12,000 26.69 US$320,274
2023-12-12 2023-12-11 PrS Proposed sale
3.8
Jian Xie

Officer

Officer
10,000
26.32
US$263,179 		10,000 26.32 US$263,179
2023-12-06 2023-12-04 S Sale
2.6
Kim Paul

CFO and Treasurer

Officer
1,437 -0.7%
27.57
US$39,623 		1,437 -0.7% 27.57 US$39,623
2023-12-06 2023-12-04 S Sale
3.8
Xie Jian

President and COO

Officer
1,779 -0.5%
27.57
US$49,053 		1,779 -0.5% 27.57 US$49,053
2023-12-06 2023-12-04 S Sale
3.7
Gao Hanlin

Chief Scientific Officer

Officer
1,437 -0.2%
27.57
US$39,623 		1,437 -0.2% 27.57 US$39,623
2023-12-04 2023-12-04 PrS Proposed sale
3.8
Jian Xie

Officer

Officer
1,779
27.57
US$49,053 		1,779 27.57 US$49,053
2023-12-04 2023-12-04 PrS Proposed sale
2.6
Paul Kim

Officer

Officer
1,437
27.57
US$39,623 		1,437 27.57 US$39,623
2023-12-04 2023-12-04 PrS Proposed sale
3.7
Hanlin Gao

Officer

Officer
1,437
27.57
US$39,623 		1,437 27.57 US$39,623
2023-11-20 2023-11-16 S Sale
2.6
Kim Paul

CFO and Treasurer

Officer
1,307 -0.6%
27.25
US$35,617 		1,307 -0.6% 27.25 US$35,617
2023-11-20 2023-11-16 S Sale
3.8
Xie Jian

President and COO

Officer
1,617 -0.4%
27.25
US$44,065 		1,617 -0.4% 27.25 US$44,065
2023-11-16 2023-11-16 PrS Proposed sale
3.8
Jian Xie

Officer

Officer
1,617
27.25
US$44,065 		1,617 27.25 US$44,065
2023-11-16 2023-11-16 PrS Proposed sale
2.6
Paul Kim

Officer

Officer
1,307
27.25
US$35,617 		1,307 27.25 US$35,617
Explore more

More insider trading research around Fulgent Genetics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America